Thymidylate synthase expression as predictive biomarker of pemetrexed sensitivity in advanced cancer patients.

11089 Background: Although a high level of thymidylate synthase (TS) expression in malignant tumours has been suggested to be related to a reduced sensitivity to the antifolate drug pemetrexed, no ...